The New Alzheimer’s Drug
This session will discuss Biogen’s new Alzheimer’s drug, Aduhelm - the first FDA-approved drug to slow the progress of this disease in the past 2 decades. We’ll explain the clinical data, and discuss implications for patients and caregivers. CaregiverTeleconnection · The New Alzheimer’s Drug July 7